◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › M › MDT

Medtronic PLC (MDT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-09-05

Medtronic PLC (MDT) operates in the Health Care Equipment industry and is headquartered in Galway, Ireland with about 95,000 employees. Its market capitalization is roughly $118 billion. In the fiscal year ended 2026-04-30, MDT reported $36.4B in revenue and $4.8B in net income.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.

Interactive charts & full statements → Open the MDT valuation workbench →

MDT Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-07-31	2026-04-30	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30	2019-04-30	2018-04-30	2017-04-30	2016-04-30	2015-04-30	2014-04-30	2013-04-30	2012-04-30	2011-04-30	2010-04-30	2009-04-30	2008-04-30	2007-04-30
Total Revenue	$37.5B	$36.4B	$33.5B	$32.4B	$31.2B	$31.7B	$30.1B	$28.9B	$30.6B	$30.0B	$29.7B	$28.8B	$20.3B	$17.0B	$16.6B	$16.2B	$15.9B	$15.8B	$14.6B	$13.5B	$12.3B
Gross Profit	$25.0B	$23.6B	$21.9B	$21.1B	$20.5B	$21.5B	$19.6B	$19.5B	$21.4B	$20.9B	$20.4B	$19.7B	$14.0B	$12.7B	$12.5B	$12.3B	$11.8B	$11.8B	$11.1B	$10.1B	$9.1B
Gross Margin %	66.7%	65.0%	65.3%	65.3%	65.7%	68.0%	65.2%	67.4%	70.0%	69.7%	68.7%	68.3%	68.9%	74.5%	75.1%	76.0%	74.1%	74.7%	75.9%	74.5%	74.2%
Operating Income (EBIT)	$6.8B	$6.5B	$6.0B	$5.1B	$5.5B	$5.8B	$4.5B	$4.8B	$6.3B	$6.6B	$5.4B	$5.4B	$3.8B	$3.8B	$4.4B	$4.5B	$4.5B	$4.8B	$3.5B	$3.7B	$3.7B
Operating Margin %	18.1%	17.8%	17.8%	15.9%	17.6%	18.1%	14.9%	16.6%	20.5%	22.2%	18.1%	18.6%	18.6%	22.4%	26.5%	27.7%	28.0%	30.3%	23.7%	27.0%	30.4%
Net Income	$5.2B	$4.8B	$4.7B	$3.7B	$3.8B	$5.0B	$3.6B	$4.8B	$4.6B	$3.1B	$4.0B	$3.5B	$2.7B	$3.1B	$3.5B	$3.6B	$3.1B	$3.1B	$2.2B	$2.2B	$2.8B
Net Margin %	13.9%	13.2%	13.9%	11.4%	12.0%	15.9%	12.0%	16.6%	15.2%	10.4%	13.6%	12.3%	13.2%	18.0%	20.9%	22.4%	19.4%	19.6%	14.9%	16.5%	22.8%
EBITDA	$9.4B	$9.8B	$9.2B	$8.2B	$8.7B	$8.8B	$7.5B	$7.8B	$9.3B	$9.5B	$8.6B	$8.5B	$5.5B	$4.9B	$5.5B	$5.3B	$4.9B	$5.1B	$3.5B	$3.8B	$4.3B
Earnings Per Share (EPS)	$4.06	$3.73	$3.61	$2.76	$2.82	$3.73	$2.66	$3.54	$3.41	$2.27	$2.89	$2.48	$2.41	$3.02	$3.37	$3.41	$2.86	$2.79	$1.93	$1.95	$2.41
Shares Outstanding (M)	1,285M	1,288M	1,290M	1,330M	1,333M	1,351M	1,354M	1,351M	1,358M	1,368M	1,391M	1,426M	1,109M	1,014M	1,028M	1,060M	1,082M	1,109M	1,126M	1,142M	1,162M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31
Total Revenue	$9.8B	$9.8B	$9.0B	$9.0B	$8.6B	$8.9B	$8.3B	$8.4B
Gross Profit	$6.3B	$7.4B	$5.9B	$5.4B	$4.9B	$5.8B	$5.5B	$5.5B
Gross Margin %	65.0%	75.9%	64.9%	60.3%	57.7%	64.8%	66.5%	64.9%
Operating Income (EBIT)	$1.8B	$1.6B	$1.8B	$1.7B	$1.4B	$1.4B	$1.6B	$1.6B
Operating Margin %	18.1%	16.0%	19.7%	18.8%	16.9%	16.1%	19.9%	19.0%
Net Income	$1.5B	$1.2B	$1.1B	$1.4B	$1.0B	$1.1B	$1.3B	$1.3B
Net Margin %	15.1%	12.7%	12.7%	15.3%	12.1%	11.8%	15.6%	15.1%
EBITDA	$2.0B	$2.6B	$2.5B	$2.4B	$2.2B	$2.3B	$2.4B	$2.4B
Earnings Per Share (EPS)	$1.14	$0.96	$0.89	$1.07	$0.81	$0.82	$1.01	$0.99
Shares Outstanding (M)	1,285M	1,288M	1,288M	1,288M	1,287M	1,288M	1,286M	1,287M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDT Free Cash Flow History

Cash flow	TTM → 2026-07-31	2026-04-30	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30	2019-04-30	2018-04-30	2017-04-30	2016-04-30	2015-04-30	2014-04-30	2013-04-30	2012-04-30	2011-04-30	2010-04-30	2009-04-30	2008-04-30	2007-04-30
Cash from Operations (CFO)	$8.0B	$7.3B	$7.0B	$6.8B	$6.0B	$7.3B	$6.2B	$7.2B	$7.0B	$4.7B	$6.9B	$5.2B	$4.9B	$5.0B	$4.9B	$4.5B	$3.7B	$4.1B	$3.9B	$3.5B	$3.0B
Capital Expenditures (CapEx)	$1.9B	$1.9B	$1.9B	$1.6B	$1.5B	$1.4B	$1.4B	$1.2B	$1.1B	$1.1B	$1.3B	$1.0B	$571M	$396M	$457M	$528M	$548M	$635M	$663M	$606M	$694M
Free Cash Flow (FCF)	$6.1B	$5.4B	$5.2B	$5.2B	$4.6B	$6.0B	$4.9B	$6.0B	$5.9B	$3.6B	$5.6B	$4.2B	$4.3B	$4.6B	$4.4B	$3.9B	$3.2B	$3.5B	$3.2B	$2.9B	$2.3B
FCF Margin %	16.3%	14.9%	15.5%	16.1%	14.7%	18.9%	16.2%	20.8%	19.2%	12.1%	18.9%	14.5%	21.4%	26.8%	26.7%	24.4%	20.0%	22.1%	22.0%	21.3%	18.6%
Dividends Paid	$3.6B	$3.6B	$3.6B	$3.7B	$3.6B	$3.4B	$3.1B	$2.9B	$2.7B	$2.5B	$2.4B	$2.1B	$1.3B	$1.1B	$1.1B	$1.0B	$969M	$907M	$843M	$565M	$504M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31
Cash from Operations (CFO)	$1.8B	$2.6B	$2.7B	$925M	$1.1B	$2.5B	$2.6B	$958M
Capital Expenditures (CapEx)	$503M	$488M	$444M	$468M	$504M	$459M	$476M	$404M
Free Cash Flow (FCF)	$1.3B	$2.1B	$2.3B	$457M	$584M	$2.1B	$2.1B	$554M
FCF Margin %	13.2%	21.3%	25.5%	5.1%	6.8%	23.2%	25.3%	6.6%
Dividends Paid	$921M	$908M	$911M	$910M	$910M	$897M	$897M	$897M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDT Balance Sheet History

Balance sheet	2026-07-31	2026-04-30	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30	2019-04-30	2018-04-30	2017-04-30	2016-04-30	2015-04-30	2014-04-30	2013-04-30	2012-04-30	2011-04-30	2010-04-30	2009-04-30	2008-04-30	2007-04-30
Total Assets	$93.3B	$93.0B	$91.7B	$90.0B	$90.9B	$91.0B	$93.1B	$90.7B	$89.7B	$91.4B	$99.8B	$99.5B	$106.7B	$37.9B	$34.8B	$33.1B	$30.4B	$28.1B	$23.7B	$22.2B	$19.5B
Cash & Cash Equivalents	$1.8B	$1.9B	$2.2B	$1.3B	$1.5B	$3.7B	$3.6B	$4.1B	$4.4B	$3.7B	$5.0B	$2.9B	$4.8B	$1.4B	$984M	$1.2B	$1.4B	$1.4B	$1.3B	$1.1B	$1.3B
Total Liabilities	$42.5B	$43.0B	$43.4B	$39.6B	$39.3B	$38.3B	$41.5B	$39.8B	$39.5B	$40.6B	$49.4B	$47.7B	$53.5B	$18.5B	$16.1B	$16.0B	$14.5B	$13.5B	$10.8B	$10.7B	$8.5B
Total Debt (Short + Long-Term)	$2.5B	$27.9B	$28.5B	$25.0B	$24.4B	$24.1B	$26.4B	$24.8B	$25.3B	$25.7B	$33.4B	$31.3B	$36.1B	$11.9B	$10.7B	$10.6B	$9.8B	$9.5B	$7.2B	$6.9B	$6.1B
Total Shareholders' Equity	$50.2B	$49.5B	$48.0B	$50.2B	$51.5B	$52.6B	$51.4B	$50.7B	$50.1B	$50.7B	$50.3B	$51.8B	$53.2B	$19.4B	$18.7B	$17.1B	$16.0B	$14.6B	$12.9B	$11.5B	$11.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDT viewer.

MDT Metric Deep Dives

Other Companies in Health Care Equipment

ABT · Abbott Laboratories — $178 billion
ISRG · Intuitive Surgical — $141 billion
SYK · Stryker Corporation — $106 billion
BSX · Boston Scientific — $63 billion
EW · Edwards Lifesciences — $51 billion
BDX · Becton Dickinson — $49 billion
IDXX · Idexx Laboratories — $40 billion
DXCM · Dexcom — $34 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← MDST All “M” companies MDTR →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.